Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on Abbott Labs (ABT)

July 19, 2024 6:17 AM
UBS analyst Danielle Antalffy reiterated a Buy rating and $143.00 price target on Abbott Labs (NYSE: ABT)The analyst comments "ABT ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles